Back

PSA - a potential biomarker for the intersection of screening for cardiovascular disease and cancer

3 April 2025 (08:00 - 19:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular protection in patients with cancer Cardiovascular Disease in Primary Care EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Ms Elisabeth Unger

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

2 More presentations in this session

Presentation thumbnail
Semaglutide and dapagliflozin synergistically prevent cancer therapy-related cardiac dysfunction in hyperglycemic conditions
Doctor V. Quagliariello (Naples, IT)
Abstract Slides
Presentation thumbnail
Cardioprotective effects of prophylactic ACE Inhibitors in anthracycline-based chemotherapy: a systematic review and meta-analysis
Mr D. Pizzi (Milano, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular protection in patients with cancer

The Event

Event poster

ESC Preventive Cardiology 2025

3 April - 5 April 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources